OMT-003

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameOMT-003

Drug Alias NameOMT-003

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors

TargetsTyrosine-protein kinase JAK2

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOhm oncology Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A